The innovation landscape: organisations involved in innovation, evaluation and adoption
As part of the planning and development of the NICE Medical Technologies Evaluation Programme, a need emerged for information about other organisations in "the innovation landscape" for healthcare in the United Kingdom, particularly in relation to devices and diagnostic products. This landscape has evolved rapidly in recent years and many of our stakeholders had told us that some kind of collation would be useful. With regard to developing the Pathway, the possibilities for useful collaboration with other organisations and avoiding duplication of effort were important considerations.
This document lists organisations involved in innovation and in development, evaluation and adoption of medical technologies ("medtech products" - devices and diagnostics) and those which promote the innovation, evaluation and adoption of medtech products in the UK. It contains brief information about each organisation including a web-sourced statement about its purpose, a website address, and the date the information was accessed. Most of this information was gathered during August 2009: this is an important point to note, because organisations in the "innovation landscape" change quite frequently, and new ones appear. This list represents a "snapshot", but it may provide a useful reference source for others interested in this area. All of the descriptions of the organisations set out below are quoted directly from the organisation's own website.
There were many ways in which the various organisations might have been listed. We have chosen to present them in three broad categories, defined by whether the main activity of each organisation seemed most relevant to medical technologies at the stage of their development, evaluation or adoption (although many of the organisations could claim to be related to more than one) as follows:
Product development/innovation
This includes organisations involved in carrying out primary research on medtech products, and in bringing them to market and regulating them. More information.
Evaluation
This includes organisations involved in assessment or analysis of primary evidence and making judgements on their value for the NHS. Read more. More information.
Adoption
This includes organisations that procure or commission medtech products and those that facilitate or encourage their uptake or adoption. More information.
This page was last updated: 02 June 2011
